Derivatives and hedging activities (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
| Derivatives and hedging activities |
|
| Schedule of amounts were recorded on the consolidated balance sheet related to cumulative basis adjustment for fair value hedges |
| | | | | | | | | | | | | Line Item in the Consolidated Balance Sheets in Which the Hedged Item is Included | | | Amortized Amount of the Hedged Assets/(Liabilities) | | | Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Assets/(Liabilities) | (Dollars in thousands) | | | March 31, 2026 | | | December 31, 2025 | | | March 31, 2026 | | | December 31, 2025 | AFS Securities (1) | | $ | 136,306 | | $ | 139,219 | | $ | 147 | | $ | 303 | Total | | $ | 136,306 | | $ | 139,219 | | $ | 147 | | $ | 303 |
| (1) | Fixed Rate AFS Securities. These amounts include the amortized cost basis of closed portfolios of fixed rate assets used to designate hedging relationships in which the hedged item is the stated amount of assets in the closed portfolio anticipated to be outstanding for the designated hedged period. At March 31, 2026, the amortized cost basis of the closed portfolios used in these hedging relationships was $136.3 million. The amounts of the designated hedged items were $25.0 million. At December 31, 2025, the amortized cost basis of the closed portfolios used in these hedging relationships was $139.2 million. The amounts of the designated hedged items were $75.0 million. |
|
| Schedule of fair value of derivative financial instruments and balance sheet classification |
| | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Values of Derivative Instruments | | | | Derivative Assets | | | Derivative Liabilities | | | | | As of March 31, 2026 (1) | | As of December 31, 2025 (1) | As of March 31, 2026 (1) | | As of December 31, 2025 (1) | (Dollars in thousands) | | | Notional Amount | | Balance Sheet Location | | | Fair Value | | Balance Sheet Location | | | Fair Value | | | Notional Amount | | Balance Sheet Location | | | Fair Value | | Balance Sheet Location | | | Fair Value | Derivatives designated as hedging instruments | | | | | | | | | | | | | | | | | | | | | | | | | | | Interest rate products | | $ | | | Other assets | | $ | | | Other assets | | $ | | | $ | 25,000 | | Other liabilities | | $ | 158 | | Other liabilities | | $ | 329 | Total derivatives designated as hedging instruments | | | | | | | $ | | | | | $ | | | | | | | | $ | 158 | | | | $ | 329 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Derivatives not designated as hedging instruments | | | | | | | | | | | | | | | | | | | | | | | | | | | Interest rate products | | $ | 408,661 | | Other assets | | $ | 14,702 | | Other assets | | $ | 15,896 | | $ | 408,661 | | Other liabilities | | $ | 14,425 | | Other liabilities | | $ | 15,659 | Other contracts | | | 37,321 | | Other assets | | | 2 | | Other assets | | | 2 | | | 6,919 | | Other liabilities | | | | | Other liabilities | | | | Total derivatives not designated as hedging instruments | | | | | | | $ | 14,704 | | | | $ | 15,898 | | | | | | | $ | 14,425 | | | | $ | 15,659 |
| (1) | The notional asset amount of interest rate swaps and risk participation agreements were $408.7 million and $37.3 million, respectively, at March 31, 2026, and $368.5 million and $34.0 million, respectively, at December 31, 2025. |
|
| Schedule of effect of derivative financial instruments on Consolidated income and comprehensive income |
| | | | | | | | | | | Location and Amount of Gain or (Loss) | | | | Recognized in Income on Fair Value and | | | | Cash Flow Hedging Relationships | | | | For the three months ended March 31, | | | | 2026 | | | 2025 | | (Dollars in thousands) | | | Interest Income | | | Interest Income | | Total amounts of income and expense line items presented in the statements of income and | | | | | | | | comprehensive income in which the effects of fair value or cash flow hedges are recorded | | $ | (68) | | $ | 255 | | | | | | | | | | The effects of fair value and cash flow hedging: | | | | | | | | (Loss) or gain on fair value hedging relationships | | | | | | | | Interest contracts | | | | | | | | Hedged items | | | (157) | | | 107 | | Derivatives designated as hedging instruments | | | 89 | | | 148 | | in earnings based on an amortization approach | | | | | | | | Gain or (loss) on cash flow hedging relationships | | | | | | | | Interest contracts | | | | | | | | Amount of (loss) reclassified from AOCI into income | | | | | | | | Amount of gain reclassified from AOCI into income - Included Component | | | | | | | | Amount of (loss) reclassified from AOCI into income - Excluded Component | | $ | | | $ | | |
|
| Schedule of gain (loss) on derivative instruments not designated as hedging instruments |
| | | | | | | | | | | | | Amount of Gain or (Loss) | | Amount of Gain or (Loss) | | | | | Recognized in | | Recognized in | | | Location of Gain or (Loss) | | Income on Derivative | | Income on Derivative | | | Recognized in Income | | Three Months Ended | | Three Months Ended | (Dollars in thousands) | | on Derivatives | | March 31, 2026 | | March 31, 2025 | Derivatives not designated as hedging instruments: | | | | | | | | | Interest rate products | | Noninterest income (expense) | | $ | 40 | | $ | (63) | Other contracts | | Noninterest income (expense) | | | | | | | Total | | | | $ | 40 | | $ | (63) | | | | | | | | | | Fee income | | Noninterest income | | $ | 620 | | $ | 106 |
|
| Schedule of offsetting derivatives |
| | | | | | | | | | | | | | | | | | | Offsetting of Derivative Assets | | | | | | | | | | | | | | | | | | | as of March 31, 2026 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gross Amounts Not Offset in the Balance Sheet | | | Gross | | | | Net Amounts | | | | | | | | | | | | Amounts of | | Gross Amounts | | of Assets | | | | | | | | | | | | Recognized | | Offset in the | | presented in the | | Financial | | Cash Collateral | | Net | (Dollars in thousands) | | Assets | | Balance Sheet | | Balance Sheet | | Instruments | | Posted | | Amount | | | | | | | | | | | | | | | | | | | | Derivatives | | $ | 14,702 | | $ | | | $ | 14,702 | | $ | | | $ | 10,060 | | $ | 4,642 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Offsetting of Derivative Liabilities | | | | | | | | | | | | | | | | | | | as of March 31, 2026 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gross Amounts Not Offset in the Balance Sheet | | | Gross | | | | Net Amounts | | | | | | | | | | | | Amounts of | | Gross Amounts | | of Liabilities | | | | | | | | | | | | Recognized | | Offset in the | | presented in the | | Financial | | Cash Collateral | | Net | (Dollars in thousands) | | Liabilities | | Balance Sheet | | Balance Sheet | | Instruments | | Posted(1) | | Amount | | | | | | | | | | | | | | | | | | | | Derivatives | | $ | 14,584 | | $ | | | $ | 14,584 | | $ | 14,584 | | $ | | | $ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Offsetting of Derivative Assets | | | | | | | | | | | | | | | | | | | as of December 31, 2025 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gross Amounts Not Offset in the Balance Sheet | | | Gross | | | | Net Amounts | | | | | | | | | | | | Amounts of | | Gross Amounts | | of Assets | | | | | | | | | | | | Recognized | | Offset in the | | presented in the | | Financial | | Cash Collateral | | Net | (Dollars in thousands) | | Assets | | Balance Sheet | | Balance Sheet | | Instruments | | Posted | | Amount | | | | | | | | | | | | | | | | | | | | Derivatives | | $ | 15,896 | | $ | | | $ | 15,896 | | $ | | | $ | 8,960 | | $ | 6,936 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Offsetting of Derivative Liabilities | | | | | | | | | | | | | | | | | | | as of December 31, 2025 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gross Amounts Not Offset in the Balance Sheet | | | Gross | | | | Net Amounts | | | | | | | | | | | | Amounts of | | Gross Amounts | | of Liabilities | | | | | | | | | | | | Recognized | | Offset in the | | presented in the | | Financial | | Cash Collateral | | Net | (Dollars in thousands) | | Liabilities | | Balance Sheet | | Balance Sheet | | Instruments | | Posted(1) | | Amount | | | | | | | | | | | | | | | | | | | | Derivatives | | $ | 15,988 | | $ | | | $ | 15,988 | | $ | 15,988 | | $ | | | $ | | | | | | | | | | | | | | | | | | | | |
| (1) | Cash collateral of $1.0 million and $2.2 million was paid as of March 31, 2026 and December 31, 2025, respectively, but not presented as an offset above. |
|